HSIC
Henry Schein
October 8, 2026 · pre-market
- Rarity
- 1.98
- Peak move
- −5.13%
- Float cap
- $8.1B
Henry Schein distributes healthcare products, services, and technology to office-based dental and medical practitioners, dental laboratories, and government or institutional clinics. It sells more than 300,000 branded and private-label items, including consumables, equipment, and practice-management software, through a centralized distribution network and a large direct sales force. The company operates mainly in North America and Europe, serving over one million customers worldwide.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
5 events · 0 from SEC or newswire · 0 timed with the movemajor_contractSouth Korean dental imaging maker Vatech signed a North American distribution partnership with Henry Schein's US unit for Vatech's US-approved dental devices including the low-dose Green CT and EzRay Air imaging systems.
ceo_cfo_departureHenry Schein CFO Ronald N. South, four years as CFO and 18 years with the company, will step down effective November 4, 2026 and move to a senior advisory role, with Emmanuel Caprais, formerly SVP and CFO of ITT Inc., named SVP and CFO effective the same date and joining as Senior Financial Advisor on October 12, 2026.
analyst_ratingBank of America Securities reiterated a Buy rating on Henry Schein and raised its price target to $110 from $90 on October 7, 2026.
peer_disclosureDentsply Sirona announced an expanded relationship with independent distributor Midwest Dental Equipment & Supply to offer its full technology portfolio, including CEREC, Primescan and Axeos/Orthophos imaging, in the US effective November 1, 2026.
product_launchHenry Schein and Chooch AI agreed to collaborate to make Chooch's AI computer-vision inventory management technology available through Henry Schein's fully managed Supply Chain Services for health systems, medical offices and labs.